Answers are grounded in this paper and cite their sources.
Neonatal lupus erythematosus (NLE) is an autoimmune disorder in which maternal antibodies, particularly anti-Sjögren's-syndrome-related antigen A autoantibodies (anti-SS-A) or anti-SS-B antibodies, cause complications in foetal or neonatal cases. We report a case of NLE in an infant born to an asymptomatic mother, presenting with fever and elevated C-reactive protein despite the absence of maternal anti-double-stranded DNA (anti-dsDNA) antibodies. The patient was a 35-day-old male infant who presented with a rash and fever. Laboratory findings included elevated C-reactive protein and ferritin, soluble interleukin-2 receptor, hypocomplementaemia, and elevated D-dimer levels. NLE or urticarial vasculitis secondary to possible infantile-onset systemic lupus erythematosus was considered in the differential diagnosis. The infant and mother tested positive for anti-SS-A and anti-SS-B antibodies, with titres decreasing over time, leading to a final diagnosis of NLE. Although anti-dsDNA antibodies are typically maternal in origin, the mother in this case was repeatedly negative, making transplacental transfer unlikely and suggesting possible de novo antibody production by the infant. Although fever is rare in NLE, this case presented with systemic symptoms similar to systemic lupus erythematosus, including fever, elevated C-reactive protein, and hypocomplementaemia. In some cases of NLE, systemic symptoms similar to systemic lupus erythematosus may be observed in addition to the rash, and anti-dsDNA antibodies may also be positive serologically.
No takes yet. Share an insight, caveat, or question.
Takemoto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: